Physician profile
Denise E Fried
NPI 1740254739
$570.79
in general payments reported to CMS, 2019-2025
10 companies · $68.46 in 2025
The $68.46 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.44 · 2022: $137 · 2023: $94.29 · 2024: $221 · 2025: $68.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $159.77 | 2021-2024 | Veozah, Myrbetriq |
| Lundbeck LLC | $81.56 | 2023-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $72.96 | 2022 | |
| Neurocrine Biosciences, INC. | $69.02 | 2023-2025 | Ingrezza |
| Lexicon Pharmaceuticals, INC. | $60.32 | 2024 | Inpefa |
| Acadia Pharmaceuticals INC | $43.34 | 2024 | Nuplazid |
| Lilly USA, LLC | $34.85 | 2023-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.25 | 2025 | |
| Pfizer INC. | $17.01 | 2024 | |
| Sun Pharmaceutical Industries INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Fried listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.